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LA Strain With Leg Lifts in Heart Failure
With Preserved Ejection FractionMasaru Obokata, MD,* Kazuaki Negishi, MD, PHD,* Koji Kurosawa, MD, PHD,*
Hitomi Arima, RMS,y Rieko Tateno, MD,* Goro Ui, MD,y Shoichi Tange, MD,y
Masashi Arai, MD, PHD,* Masahiko Kurabayashi, MD, PHD*
Maebashi, JapanOBJECTIVES The purposes of this study were to examine left atrial (LA) functional reserve in
patients with heart failure (HF) with preserved ejection fraction (HFpEF) and to determine whether LA
strain has an incremental diagnostic value over clinical and conventional echocardiographic parameters.
BACKGROUND Patients with HFpEF have multiple cardiovascular reserve abnormalities. Although
the LA is dysfunctional in HFpEF, the diagnostic value of LA strain remains unknown.
METHODS The LA at rest and during passive leg lifts was echocardiographically assessed in 40
patients with HFpEF and in 46 patients with hypertension without HF (HT controls). Global peak atrial
longitudinal strain during ventricular systole (global LAS) and booster strain during atrial contraction
(global LAB) were assessed using speckle tracking.
RESULTS Patients with HFpEF had an enlarged LA and reduced LA emptying fraction compared
with HT controls at rest, while LA stroke volume (SV) was similar between the groups. During leg lifts,
increases in LA reservoir and contractile function (i.e., global LAS and LAB) were blunted in HFpEF
patients compared with HT controls, resulting in impaired LASV responses. Global LAS and LAB during
leg lifts accurately differentiated HFpEF from HT controls (areas under the curve: 0.95 and 0.92,
respectively). Resting global LAS had a signiﬁcant incremental diagnostic value over clinical (age
and sex) and conventional echocardiographic parameters (E/E0 ratio, left ventricular mass index,
and maximum LA volume index) (global chi-square: 49.6 vs. 30.8; p < 0.0001). The diagnostic value
was further improved by adding global LAS during leg lifts (global chi-square: 72.2 vs. 49.6;
p < 0.0001).
CONCLUSIONS An enlarged LA compensates for LA dysfunction and maintains LASV at rest in
patients with HFpEF. However, depressed LA reserve affects LA performance during leg lifts. Evaluation
of LA function, including LA strain using leg lifts, might provide incremental diagnostic value for
HFpEF. (J Am Coll Cardiol Img 2013;6:749–58) ª 2013 by the American College of Cardiology
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750nderstanding about the pathophysiological but without a history of HF (HT controls) during
mechanisms of heart failure (HF) with
preserved ejection fraction (HFpEF) has
recently improved. This condition is not
simply the result of a single impairment in left
ventricular (LV) diastolic function, but rather an
accumulation of multiple domains of cardiovascular
dysfunction (1). One of the most distinct features of
HFpEF is increased LV and vascular stiffness,
which contributes to pathophysiology and cardio-
vascular reserve dysfunction in such patients.See page 759Left atrial (LA) function in close interdepen-
dence with LV function plays an important role
in maintaining optimal cardiac performance bynal
l
nal
stole
dex
ss
rymodulating LV ﬁlling. Several in-
vestigations have found that as diastolic
dysfunction progresses, the relative
contribution of LA function to LV ﬁlling
increases at early stage and later declines,
at least partly because of increasing LA
stiffness (2,3). Those ﬁndings imply that a
decrease in LA compliance plays a key role
in the pathophysiology of HFpEF. How-
ever, the mechanisms through which LA
stiffness contributes to the development of
HFpEF remain unknown. We hypothe-
sized that LA functional reserve would be
impaired in patients with HFpEF.
Speckle tracking echocardiography en-
ables a precise assessment of the function
of the LA, including its stiffness, and thefeasibility and reproducibility of speckle tracking
have been established (4). The purposes of this
study were to examine LA functional reserve in
patients with HFpEF and to determine whether LA
strain has an incremental diagnostic value over
clinical and conventional echocardiographic
parameters.
METHODS
Study population. We studied 48 consecutive pa-
tients who were diagnosed with HFpEF based on
the guidelines of the European Society of Cardiol-
ogy (5) and referred to our hospital for pulmonary
edema due to HF. Patients with acute coronary
syndrome, atrial ﬁbrillation, more than mild valvular
heart diseases, cardiomyopathies, pulmonary disease
and inadequate images were excluded. We included
48 consecutive individuals with hypertension (HT)the same period. All patients were assessed by
echocardiography while in a compensated state at
discharge. The institutional medical ethics com-
mittee of Maebashi Red Cross Hospital approved
the study protocol, and all participants provided
written informed consent.
Standard echocardiography. An experienced so-
nographer performed all echocardiographic studies
using a portable device (Vivid i, GE Medical,
Milwaukee, Wisconsin) equipped with a 2.5-MHz
transducer. All patients underwent echocardiogra-
phy in a supine or slightly left decubitus position.
Both LV and LA volumes were quantiﬁed
according to the recommendations of the American
Society of Echocardiography (6). LA volumes were
calculated using the biapical area-length method
and subsequently indexed by body surface area (7) to
measure maximum, pre-A, and minimum LA vol-
ume indices (LAVImax, LAVIpre-A, and LAVImin).
Total, passive, and active LA stroke volume (SV)
and LA emptying fraction were assessed as
previously described (4,8).
Transmitral ﬂow (E-wave, A-wave, and deceler-
ation time [DecT]) and mitral annular tissue-
Doppler (E0, A0, and S0) velocities were measured,
and the E/E0 ratio was used to estimate pulmonary
capillary wedge pressure (PCWP).
Echocardiography during leg lifts. Measurements
were repeated during passive leg lifts and care was
taken to obtain the same imaging planes of the LA
as in the baseline. An assistant carefully held the
patient’s legs at 60 to maintain the position of the
patient’s thorax. During leg lifts, the sonographer
focused solely on capturing the same imaging planes
as those in the baseline images. After 3 min of
passive leg lifts, data were acquired during leg raises
(9). LA lengths at rest and during leg lifts were
52  6 mm and 53  6 mm, respectively (r ¼ 0.84;
p < 0.001; difference ¼ 1.3  3.4 mm).
Speckle tracking echocardiography. Three consec-
utive cardiac cycles were recorded and averaged. The
frame rate was set between 60 and 80 frames/s. Data
were analyzed off-line using a customized software
package (EchoPAC, GE, Milwaukee, Wisconsin).
We used the onset of the R-wave as the reference
point to calculate LA strain (10). The LA endo-
cardial border was manually traced in 4- and
2-chamber views. After manual adjustment of the
region of interest to cover the full thickness of the
myocardium, the software divided it into 6 segments
and automatically scored segmental tracking quality.
Segments in which image quality was inadequate
were rejected by the software and excluded from
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751analysis. Longitudinal strain curves were generated
for each of 12 atrial segments in 4- and 2-chamber
views. Because longitudinal strain curves were lower
in 2 segments of the LA roof than in the other 4
segments, they were excluded from the 4- and
2-chamber views (Fig. 1) (11). Global peak atrial
longitudinal strain during ventricular systole (global
LAS) and booster strain during atrial contraction
(global LAB) were then measured by averaging
values obtained in the other eight LA segments.
Because the initial strain was set at the ventricular
end-diastole, these strains are presented as positive
values in this method (10).
The LV longitudinal strain was assessed using
speckle tracking. The LV endocardium in end-
diastole was traced in 4-, 2-, and 3-chamber
views, and the thickness of region of interest was
adjusted to include the entire myocardium. The
software automatically tracks myocardial motion
and results were displayed. LV global strain was
deﬁned as the average of values for longitudinal
global strain obtained in 4-, 2-, and 3-chamber
images. We also measured LV basal strain by
averaging the strain values of four LV bases (ante-
rior, lateral, septal, and inferior). The same examiner
performed all echocardiographic measurements.Figure 1. Representative Curves Showing Left Atrial Strain
Strain curves from speckle tracking in apical 4-chamber view. LAB ¼ pe
LAS ¼ peak atrial longitudinal strain during ventricular systole.Estimation of LA stiffness. Because LA stiffness
can be evaluated using the ratio of invasively
measured PCWP to global LAS (12), we deﬁned
the estimated LA stiffness as E/E0 ratio/global
LAS (2).
Statistical analysis. Continuous variables are shown
as mean  SD unless otherwise speciﬁed.
Categorical variables were analyzed using Fisher’s
exact test. Normality was evaluated by the Shapiro-
Wilk W test. Comparisons between groups were
assessed using Student’s t test and the Mann-
Whitney U test for normally and non-normally
distributed data, respectively. Normally and non-
normally intragroup distributed data were com-
pared using a paired t test and the Wilcoxon signed
rank test, respectively. Baseline group differences
were adjusted using general linear models. The
diagnostic ability of LA strain to distinguish
HFpEF from HT controls was determined using
receiver-operating characteristic curves. The area
under the curve (AUC) for each parameter was
compared using paired analyses (13) with Bonfer-
roni correction. The optimal cutoff was taken when
the sum of sensitivity and speciﬁcity was the high-
est. Multivariate models were created to assess the
independent diagnostic value of global LAS adjustedak atrial longitudinal booster strain during atrial contraction;
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752for clinical data and echocardiographic ﬁndings.
The incremental value was assessed by comparing
the global chi-square values for each model. The
reproducibility of LA strain was assessed in
20 randomly selected individuals. Intraobserver and
interobserver variability were evaluated by having
the same observer and another experienced
reader repeat the analysis and they are reported as
interclass correlation coefﬁcients (ICCs). A value of
p < 0.05 was considered to indicate statistical sig-
niﬁcance. We compared receiver-operating charac-
teristic curves using MedCalc version 12.1.4
(MedCalc Software, Mariakerke, Belgium), and all
other data were statistically analyzed using SPSS
version 19.0 (SPSS Inc., Chicago, Illinois).Table 1. Baseline Clinical Characteristics
HFpEF
(n [ 40)
Clinical characteristics
Age, yrs 77  13
Sex, M/F 14/26
Body mass index, kg/m2 21.4 (18.9 to 25.2)
Concomitant conditions
Hypertension 35 (88)
Diabetes mellitus 14 (35)
Coronary artery disease 11 (28)
Dyslipidemia 16 (40)
Current smoking 8 (20)
NYHA functional class I/II 20/20
Systolic blood pressure, mm Hg 129  20
Laboratory values
eGFR, ml/min/1.73 m2 46 (33 to 67)
Brain natriuretic peptide, pg/ml 128 (73 to 301)
Hemoglobin, g/dl 11.8  1.7
Medications
Beta-blockers 11 (28)
ACEI/ARB 22 (55)
Loop diuretic 21 (53)
Statin 7 (18)
Echocardiographic parameters
LV mass index, g/m2 144 (113 to 167)
LV end-diastolic diameter, mm 44 (39 to 49)
Septal wall thickness, mm 12.0 (11.0 to 13.8)
Posterior wall thickness, mm 12.0 (10.0 to 13.0)
LV global strain, % 13.4 (14.8 to 10
LV basal strain, % 13.9 (15.4 to 10
Values are mean  SD, n, median (interquartile range), or n (%).
ACEI/ARB ¼ angiotensin-converting enzyme inhibitor/angiotensin-receptor block
preserved ejection fraction; HT ¼ hypertension; LV ¼ left ventricular; NYHA ¼ NewRESULTS
Baseline clinical characteristics. Of the 96 enrolled
subjects, 8 patients with HFpEF and 2 HT controls
were excluded due to poor-quality echocardio-
graphic ﬁndings (n ¼ 5), atrial ﬁbrillation (n ¼ 3),
and moderate mitral valvular disease (n ¼ 2).
Therefore, data were analyzed from 40 patients with
HFpEF and 46 HT controls. Table 1 shows the
baseline clinical characteristics. Age, sex, body mass
index, and systolic blood pressure were similar
between groups. Chronic kidney disease was more
prevalent among the patients with HFpEF, but the
prevalences of HT, diabetes mellitus, coronary
artery disease, dyslipidemia, and current smokingHT Controls
(n [ 46) p Value
75  10 0.106
24/22 0.131
22.7 (20.1 to 25.0) 0.653
46 (100) 0.092
10 (22) 0.229
10 (22) 0.615
23 (50) 0.391
4 (9) 0.211
–/– –
136  19 0.096
65 (49 to 75) 0.010
38 (21 to 90) <0.001
12.8  1.9 0.023
8 (17) 0.304
23 (50) 0.671
7 (15) <0.001
10 (22) 0.787
115 (93 to 140) <0.001
44 (40 to 48) 0.850
11.0 (10.0 to 13.0) 0.010
11.0 (9.0 to 12.0) 0.097
.1) 18.0 (19.9 to 16.1) 0.001
.0) 17.6 (20.0 to 15.4) <0.001
ers; eGFR ¼ estimated glomerular ﬁltration rate; HFpEF ¼ heart failure with
York Heart Association.
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753were similar between the groups. The brain natri-
uretic peptide concentration was signiﬁcantly higher
and hemoglobin level was lower in patients with
HFpEF, who were also more likely to be receiving
loop diuretics. Other medications did not signiﬁ-
cantly differ between groups.
Resting LV structure and function. The LV mass
index (LVMI) and septal wall thickness were
signiﬁcantly higher in patients with HFpEF than in
HT controls (Table 1). At rest, LV end-diastolic
volume, LV end-systolic volume, LVEF, and
LVSV were similar between groups (Table 2).
However, patients with HFpEF had signiﬁcantly
lower S0, LV global, and basal strain values than did
the HT controls. These results indicated that
patients with HFpEF had pathological LV hyper-
trophy with depressed longitudinal systolic function
despite having a preserved EF.
Resting E/A ratio, DecT, and isovolumic
relaxation time did not differ between the groups.
However, patients with HFpEF had signiﬁcantly
lower E0 and A0, and higher E/E0 ratio, than did
HT controls.
LA volumes, function, strain, and stiffness. The total
and active LA emptying fractions were signiﬁcantly
lower in patients with HFpEF at rest, whereas theTable 2. Effects of Leg Lifts on Heart Rate, Left Ventricular Volume
At Rest
HFpEF Controls
p
Betwe
Heart rate, beats/min 72 (61–82) 63 (56–70)
LV end-diastolic volume, ml 59 (47–79) 59 (54–73)
LV end-systolic volume, ml 22 (15–34) 23 (19–29)
LV ejection fraction, % 60 (51–69) 63 (59–68)
LV stroke volume, ml 35 (28–44) 39 (32–46)
E wave, cm/s 67 (44–86) 59 (52–71)
A wave, cm/s 84 (62–102) 86 (77–100)
E/A ratio 0.79 (0.60–1.01) 0.71 (0.59–0.78)
Deceleration time, ms 225 (187–286) 256 (208–282)
Isovolumic relaxation
time, ms
92 (69–127) 86 (69–105)
E0 , cm/s 3.4 (2.5–4.0) 4.8 (4.0–5.9) <
A0 , cm/s 6.3 (5.0–7.5) 8.9 (8.0–10.6) <
S0 , cm/s 4.5 (4.1–6.0) 6.3 (5.1–7.0) <
E/E0 18.9 (15.7–24.9) 12.1 (9.5–16.9) <
TAPSE, cm 13.9 (12.6–17.1) 17.6 (15.0–20.2)
Values are median (interquartile range).
A ¼ late mitral diastolic inﬂow velocity; A0 ¼ late diastolic mitral annular velocity; E
velocity; TAPSE ¼ tricuspid annular plane systolic excursion; other abbreviations aspassive fraction was not (Table 3). On the other
hand, LA volume indices, such as LAVImax,
LAVIpre-A, and LAVImin, were signiﬁcantly higher
in patients with HFpEF than in HT controls. Thus,
LASV values were similar between the HFpEF
patients and HT controls. These results indicated
that LA enlargement compensated for the reduced
LA emptying fraction to maintain LASV. Global
LAS and LAB strain were signiﬁcantly lower in
patients with HFpEF, whereas LA stiffness was
signiﬁcantly higher in patients with HFpEF.
Overall differences in resting LV/LA volumes/me-
chanics remained signiﬁcant after adjustment for
estimated glomerular ﬁltration rate.
Effects of leg lifts on LV function. During leg lifts,
the increase in LVSV was blunted in patients with
HFpEF (Fig. 2A). Reﬂecting this, increased preload
signiﬁcantly raised E-wave, which resulted in el-
evated E/A ratio in those patients. In contrast,
although E0 was signiﬁcantly increased with leg lifts
in HT controls, it remained unchanged in the pa-
tients with HFpEF (Table 2). The baseline E/E0
ratio remained signiﬁcantly higher in the patients
with HFpEF than in the HT controls during leg lifts.
These results suggest that leg lifts caused a more
restrictive ﬁlling pattern in the patients with HFpEF.s, and Function in Patients With HFpEF Versus Controls With Hypertension
Leg Lifts
p Value for
Leg Lifts Versus at Rest
Value
en Groups HFpEF Controls
p Value
Between Groups HFpEF Controls
0.005 72 (62–81) 68 (61–75) 0.067 0.143 <0.001
0.678 64 (49–75) 64 (55–74) 0.488 0.217 0.309
0.924 26 (20–34) 23 (18–26) 0.062 0.026 0.250
0.210 60 (48–65) 65 (61–69) <0.001 0.002 0.083
0.172 36 (24–43) 43 (37–48) 0.003 0.149 0.050
0.382 73 (51–99) 71 (58–87) 0.588 <0.001 <0.001
0.280 86 (67–99) 94 (78–108) 0.053 0.481 <0.001
0.070 0.92 (0.65–1.10) 0.76 (0.67–0.90) 0.082 <0.001 0.002
0.074 180 (155–259) 225 (183–265) 0.045 0.005 <0.001
0.133 92 (77–121) 78 (63–97) 0.011 0.735 0.016
0.001 3.6 (2.6–4.7) 5.1 (4.5–6.9) <0.001 0.141 0.001
0.001 6.2 (5.0–7.6) 9.4 (8.6–11.1) <0.001 0.106 0.019
0.001 4.6 (3.7–6.1) 6.4 (5.2–7.7) <0.001 0.041 0.971
0.001 21.6 (14.9–31.0) 13.9 (9.3–17.2) <0.001 0.022 0.056
0.001 15.5 (14.1–18.4) 19.8 (17.1–21.8) <0.001 0.001 <0.001
¼ early mitral diastolic inﬂow velocity; E0 ¼ early diastolic mitral annular velocity; S0 ¼ systolic mitral annular
in Table 1.
Table 3. Effects of Leg Lifts on Left Atrial Volumes, Function, Strain, and Stiffness in Patients With HFpEF Versus Controls With Hypertension
At Rest Leg Lifts
p Value for
Leg Lifts Versus at Rest
HFpEF Controls
p Value
Between Groups HFpEF Controls
p Value
Between Groups HFpEF Controls
LA volume index
Maximum, ml/m2 50 (42–69) 38 (31–45) <0.001 51 (41–68) 43 (35–53) 0.009 0.882 <0.001
Pre-A, ml/m2 41 (32–54) 29 (24–35) <0.001 38 (31–51) 31 (25–40) 0.002 0.248 0.003
Minimum, ml/m2 32 (20–46) 17 (13–22) <0.001 29 (23–42) 19 (14–26) <0.001 0.925 0.005
LA emptying fraction
Total, % 41 (30–52) 55 (47–62) <0.001 40 (35–48) 55 (47–61) <0.001 0.784 0.640
Passive, % 22 (11–27) 23 (17–33) 0.064 22 (16–29) 28 (18–34) 0.027 0.139 0.076
Active, % 25 (19–36) 38 (31–49) <0.001 25 (16–31) 40 (31–50) <0.001 0.154 0.781
LA stroke volume
Total, ml 32 (24–38) 31 (25–36) 0.910 33 (25–36) 35 (28–43) 0.019 0.872 <0.001
Passive, ml 16 (7–20) 14 (8–19) 0.663 17 (12–20) 17 (10–25) 0.597 0.162 0.004
Active, ml 16 (11–20) 16 (13–21) 0.579 14 (10–19) 19 (13–24) 0.009 0.136 0.339
Global LAS, % 23 (18–27) 36 (29–40) <0.001 21 (15–26) 39 (33–44) <0.001 0.068 <0.001
Global LAB, % 13 (8–16) 18 (15–22) <0.001 11 (8–14) 20 (17–22) <0.001 0.197 0.004
LA stiffness 0.95 (0.53–1.39) 0.36 (0.30–0.54) <0.001 1.16 (0.60–1.76) 0.33 (0.26–0.49) <0.001 0.003 0.016
Values are median (interquartile range).
Global LAB ¼ global left atrial longitudinal booster strain during atrial contraction; Global LAS ¼ global left atrial longitudinal strain during ventricular systole; LA ¼ left atrial; Pre-A ¼ pre atrial
contraction; other abbreviations as in Table 1.
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754LA reserve responses during leg lifts. The increase
in LAVmax during leg lifts was lower in the patients
than in HT controls (Fig. 2B), and the increase in
global LAS was blunted in the patients with HFpEF
(Fig. 2C). These ﬁndings suggest that the patients
with HFpEF had depressed reserve capacity for LA
reservoir function. The increase in LA contractility
assessed by A0 and global LAB was lower in the
patients with HFpEF than in the HT controls
during leg lifts (Figs. 2D and 2E). Consequently,
augmentation in total LASV was signiﬁcantly
reduced in patients with HFpEF (Fig. 2F). All
differences in LV and LA reserve remained signif-
icant after adjustment for estimated glomerular
ﬁltration rate.
Discrimination of patients with HFpEF from HT
controls. Both global LAS and LAB at rest could
distinguish patients with HFpEF from HT con-
trols, with AUCs of 0.88 and 0.81, respectively
(Fig. 3). Importantly, the diagnostic accuracy was
signiﬁcantly higher for both global LAS and LAB
during leg lifts than for resting global LAS and
LAB, respectively (AUC: 0.95 and 0.92, respec-
tively; Bonferroni-adjusted p < 0.05). Global LAS
and global LAB of <31.2% and <15.2%, respec-
tively, during leg lifts discriminated HFpEF from
HT controls, with sensitivities of 90% and 89%,
respectively, and speciﬁcities of 83% and 94%.Independent and incremental diagnostic value of LA
strain over clinical characteristics and conventional
echocardiographic measurements. Multivariate anal-
ysis adjusted for age, sex, conventional echo-
cardiographic values (E/E0 ratio, LVMI, and
LAVImax), and log-transformed brain natriuretic
peptide revealed global LAS during leg lifts as an
independent discriminator of HFpEF (odds ratio:
0.77; 95% CI: 0.66 to 0.89). Furthermore, add-
ing resting global LAS improved the model based
on clinical data and conventional echocardio-
graphic values (Fig. 4). The diagnostic value was
further improved by adding global LAS during
leg lifts.
Intraobserver and interobserver variability. The
ICC values for intraobserver variability for global
LAS and LAB determined at rest were 0.94 and
0.95, respectively, and during leg lifts were 0.96 and
0.95. The ICC values for interobserver variability at
rest were 0.96 and 0.95, respectively, and during leg
lifts were 0.94 and 0.84.
D I SCUSS ION
We comprehensively assessed LA strain at rest
and during passive leg lifts in patients with
HFpEF and in HT controls. We found that a
larger LA volume in patients at rest was not
Figure 2. Responses of LV and LA during Leg Lifts in Patients With HFpEF and HT Controls
(A) Patients with HFpEF (blue bars) had reduced LV stroke volume response during leg lifts compared with HT controls (pink bars).
(B, C) Reserve in LA reservoir function was blunted in HFpEF during leg lifts, evidenced by blunted increases in LA volumemax and global LAS.
(D, E) LA contractile reserve (increases in A0 and global LAB) was also depressed in HFpEF. (F) These abnormalities led to impaired total
LA stroke volume response. D ¼ peak change; HFpEF ¼ heart failure with preserved ejection fraction; HT ¼ hypertensive. LA ¼ left atrial;
LA volumemax ¼ maximum left atrial volume; LV ¼ left ventricular; other abbreviations as in Figure 1.
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Figure 3. Discrimination of HFpEF Patients from HT Controls
The diagnostic accuracy of global LAS and LAB during leg lifts was
signiﬁcantly higher than that of resting global LAS and LAB,
respectively. *p < 0.05 versus global LAS at rest (with Bonferroni
correction); yp < 0.05 versus global LAB at rest (with Bonferroni
correction). Abbreviations as in Figure 1.
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755associated with reductions in LASV and LVSV
despite increased LA stiffness and a reduced LA
emptying fraction. Increases in LA reservoir and
contractile function during leg lifts were blunted
in the patients with HFpEF, resulting in a
depressed LASV response. Global LAS during leg
lifts distinguished patients with HFpEF from HT
controls with excellent diagnostic accuracy and
provided independent and incremental diagnostic
value over clinical and conventional echocardio-
graphic parameters.
Compensatory LA dilation in HFpEF. We found that
patients with HFpEF had a dilated LA and reduced
LA strain at rest, which was consistent with previ-
ous ﬁndings (2,3). Dilation of the LA is likely to be
an adaptive change in HFpEF to compensate for
the increase in LV ﬁlling pressure that occurs with
increasing severity of diastolic dysfunction (14).
With the increase in LV ﬁlling pressure, LA dila-
tion works as a compensatory mechanism via the
LA Frank-Starling mechanism (8). Chronically
elevated LV ﬁlling pressure and comorbidities such
as HT, diabetes mellitus, chronic kidney disease,
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Figure 4. Incremental Diagnostic Value of LA Strain Over Clinical Data and
Conventional Echocardiographic Values
Resting global LAS had signiﬁcant incremental diagnostic value over age, sex, and con-
ventional echocardiographic values. Diagnostic value was improved by adding global LAS
during leg lifts. E/E0 ratio ¼ ratio of early mitral diastolic inﬂow velocity to early diastolic
mitral annular velocity; LAVImax ¼ maximum left atrial volume index; LVMI ¼ left ventricular
mass index; other abbreviations as in Figures 1 and 2.
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756and atrial ﬁbrillation promote further LA dilation,
as well as the hypertrophy and interstitial ﬁbrosis
that characterize LA remodeling (15). Conse-
quently, these structural changes might decrease LA
compliance, reservoir, and contractile function (16).
Our ﬁnding that an increase in LA volume was not
associated with the reductions in LASV and LVSV
in resting patients with HFpEF suggests that the
enlarged LA helps to preserve LV ﬁlling despite LA
dysfunction.
Reduced LA reserve in HFpEF. The LA reserve
function was blunted in response to increased preload
in patients withHFpEF. Recent studies have focused
on the importance of abnormalities in multiple
cardiovascular reserve function in HFpEF (1). Our
ﬁndings are consistent with those from a previous
study showing a blunted A0 response in patients with
HFpEF during handgrip exercise (3). Because a
stiffer LA has reduced reservoir function in patients
with HFpEF, increased preload from the pulmonary
vein cannot enlarge the volume of theLA, resulting in
a limited ability to use the LA Frank-Starling
mechanism. Consequently, augmentation during
LV ﬁlling might be inadequate.
Value of LA strain assessment by passive leg lifts in
HFpEF. This study showed that global LAS during
leg lifts can be an incremental diagnostic parameter
for HFpEF. Whereas invasive measurements of LVpressure by cardiac catheterization remain the gold
standard for a diagnosis of HFpEF and should be
considered in patients with unexplained HF symp-
toms (17), noninvasive evaluation using echocardi-
ography plays an important role in routine clinical
practice. The American Society of Echocardiogra-
phy and the European Association of Echocardi-
ography recently released recommendations for the
classiﬁcation of diastolic dysfunction, which incor-
porate several parameters reﬂecting various LV
diastolic properties (18). However, Unzek et al. (19)
showed that remaining ambiguity was sufﬁcient to
lead to suboptimal interobserver agreement
regarding diagnoses. Thus, new markers of diastolic
dysfunction are required to improve the accuracy of
HFpEF diagnosis.
Although global LAS and LAB at rest have
excellent discrimination between HFpEF and HT
controls (2), diagnostic accuracy of these parameters
obtained during leg lifts was signiﬁcantly improved.
Recent studies have demonstrated that passive leg
lifts can detect concealed abnormalities in LV
diastolic dysfunction (17,20). Because patients with
HFpEF have abnormal cardiovascular reserve
during exercise stress (1), evaluating HFpEF during
stress might provide important information. We
found that disparities in LA reservoir and contrac-
tile function (that is, global LAS and LAB) between
HFpEF and HT controls became more pronounced
during leg lifts and that the 2 conditions could be
clearly discriminated.
We also demonstrated that global LAS during leg
lifts had independent and incremental diagnostic
value over clinical and conventional echocardio-
graphic data that comprise the diagnostic algorithms
of the European Society of Cardiology (5).
Clinical implications. Although HFpEF is mostly a
disease of the elderly (21), and exercise testing
should be considered when values determined at
rest are unremarkable (17), maximal exercise is
sometimes unfeasible in such patients. However,
diagnostic stress testing might still be required. All
such patients could perform passive leg lifts
regardless of health status, and additional cost is
not imposed. Values obtained in this manner added
incremental information to routine bedside echo-
cardiographic ﬁndings. From this viewpoint,
assessing LA strain during leg lifts might be used as
a diagnostic test for HFpEF, especially among
elderly patients.
Study limitations. Pressures were not directly
measured by invasive cardiac catheterization but
were estimated from noninvasive echocardio-
graphic surrogates. In this study, PCWP was
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757estimated using E/E0 ratio, which may be less
accurate in normal individuals with normal LV
relaxation (22). However, PCWP can be estimated
in patients with cardiac disease using the E/E0
ratio (18). We believe that this method was valid
for our control subjects who had hypertension with
impaired LV relaxation, and the E/E0 ratio has
proven reliable in HFpEF (23). Although care was
taken to acquire the same image planes as in the
baseline, views might have differed somewhat
during leg lifts. However, such differences could
similarly occur in both groups, and variable
changes in atrial volume between groups were
unlikely to be due to different views. Pulmonary
HT is often associated with HFpEF, and esti-
mated pulmonary artery systolic pressure using
Doppler echocardiography might provide nonin-
vasive diagnostic information about HFpEF (17).
However, because patients with HFpEF have a
higher prevalence of chronic obstructive pulmonary
disease (24), pulmonary artery pressure could be
overestimated in this population. Patients with
paroxysmal atrial ﬁbrillation might not be
completely excluded due to its paroxysmal nature.
However, we believe that this is very rare because
all patients with HF were carefully monitored bycontinuous ECG during at least 71.0% of hospi-
talization (94.6  7.3% of hospital stay). Finally, a
larger prospective study is warranted as our patient
cohort was relatively small.
CONCLUS IONS
An enlarged LA in HFpEF patients compensated
for LA dysfunction and maintains LASV at rest.
However, depressed LA reserve affected LA per-
formance during leg lifts. Evaluation of LA function
including LA strain using passive leg lifts might
provide incremental diagnostic value for HFpEF.Acknowledgments
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